- Low
- 80,000
- Average
- 102,527
- Median
- 100,000
- High
- 145,000
Dendreon Salary
52
100
34
Dendreon average salary is $102,527, median salary is $100,000 with a salary range from $80,000 to $145,000.
Dendreon salaries are collected from government agencies and companies. Each salary is associated with a real job position. Dendreon salary statistics is not exclusive and is for reference only. They are presented "as is" and updated regularly.
Dendreon salaries are collected from government agencies and companies. Each salary is associated with a real job position. Dendreon salary statistics is not exclusive and is for reference only. They are presented "as is" and updated regularly.
Related Dendreon Salary
Calculate how much you could earn
It's FREE. Based on your input and our analysis. How we do it?
All fields are required for calculation accuracy.
- We will send you an email to access your personalized report.
- We won’t share your email address
Dendreon salary is full-time annual starting salary. Intern, contractor and hourly pay scale vary from regular exempt employee. Compensation depends on work experience, job location, bonus, benefits and other factors.
Real Jobs Salary - Salary List- 8.5 million company & government reported salaries with date & location
- Salary calculator rank & calculate your salary
- 151 million W-2s pay scale statistics in U.S.
- Salary Map helps you navigate location based salary information
- State & City Salary provides wage data by metropolitan areas
- Company Salaries has salaries data from over 200,000 companies
Guyp Salary Dendreon Jobs
| See more Dendreon Jobs» | |
| Search All Jobs | |
Dendreon... Information
- Dendreon Corporation
- Industry: BioTech/Drugs
- City: Seattle, WA
- Dendreon Corporation is a biotechnology company developing targeted therapies for cancer. Dendreon currently has three vaccine candidates in clinical trials -- Provenge, for the treatment of prostate cancer; Mylovenge(TM), for the treatment of multiple myeloma; and APC8024, for the treatment of breast, ovarian and colon cancers. Dendreon's product pipeline also includes monoclonal antibodies and a pathway to small molecules. Dendreon has established important alliances with industry leaders Genentech, Johnson & Johnson Pharmaceutical Research & Development and Kirin Brewery Co., Ltd.
